660 articles|Clear filters
General AML, IDH1/2
Enasidenib found to induce molecular remissions in IDH2-mutated, relapsed/refractory acute myeloid leukemia
Zara Kassam
,
Feb 20, 2019
General AML
CAR T Cell Meeting 2019 | CAR T-cell therapy for acute myeloid leukemia
Philippa Redondo
,
Feb 19, 2019
General AML
The FLAGM regimen in younger adult patients with relapsed or refractory acute myeloid leukemia
Philippa Redondo
,
Feb 14, 2019
General AML, IDH1/2, & 1 more
ASH 2018 | Practice changing abstracts in acute myeloid leukemia
Andrew Wei
Charles Craddock
Gail J. Roboz
Gert Ossenkoppele
,
Feb 13, 2019
General AML
Venetoclax monotherapy in elderly patients with secondary acute myeloid leukemia
Philippa Redondo
,
Feb 12, 2019